The Henry McFarland NAIMS Workshop 2027
Molecular PET Imaging in Multiple Sclerosis, From Disease Mechanisms to Clinical Translation
March 10, 2027
Sheraton Phoenix Downtown
Phoenix, Arizona
The Henry McFarland NAIMS Workshop 2027 will be taking place Wednesday, March 10 from 8:30 am - 6:30 pm at the Sheraton Phoenix Downtown in Phoenix, Arizona. The workshop will be held ahead of the ACTRIMS Forum 2027, taking place March 11-13 2027.
| Registration Fees |
|
|---|---|
| Delegate: professional employed by academic institution, hospital, government agency, or non-profit organization. | $100 |
| Young Investigator: student/trainee OR professional who has obtained an advanced degree (M.D. or Ph.D.) within seven years (2020 or later) of the time of the Forum. Proof is required. | $50 |
| Industry Representative: Professional who holds a non-research position and is employed by a pharmaceutical company or commercial entity. | $150 |
2027 Workshop Planning Committee
Matthew Brier
Washington University in St. Louis
Korhan Buyukturkoglu
Columbia University
Richard Dortch
Barrow Neurological Institute
Leorah Freeman
Dell Medical School, The University of Texas at Austin
Susan Gauthier
Weill Cornell Medical College
Charles Guttman
Brigham and Women's Hospital
Dejan Jakimovski
Buffalo Neuroimaging Analysis Center, University at Buffalo, Neurology Department
Ajay Kumar
University of Pennsylvania
Caterina Mainero
Massachusetts General Hospital
Sridar Narayanan
McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University
Bart Rypma
University of Texas at Dallas
Burcu Zeydan
Mayo Clinic
Our Partners
If you’re interested in sponsorship opportunities, please refer to our sponsorship prospectus for more information.
Workshop Agenda
The Henry McFarland NAIMS Workshop 2027 will take place Wednesday, March 10, 2027. All times are listed in Mountain Standard Time (MST). This schedule is subject to change.
- 9:00 - 9:20 am: Imaging Inflammation: TSPO Across Its Generations, and What Lies Beyond — Burcu Zeydan (Mayo Clinic)
- 9:20 - 9:40 am: Imaging Myelin: Tracers for Demyelination and Repair — Pedro Brugarolas (Massachusetts General Hospital)
- 9:40 - 10:00 am: Imaging Neurodegeneration: Synaptic and Neuronal Targets Borrowed From Other Diseases — David Matuskey (Yale)
- 10:00 - 10:20 am: Imaging Metabolic Stress: Glucose, Oxidative Injury, and Hypoxia
- 10:50 - 11:10 am: Quantifying the Signal: AI-Assisted Analysis and PET-MRI Integration — Julie Price (Massachusetts General Hospital)
- 11:10 - 11:30 am: Acquiring the Signal: Integrated MR-PET, Digital Detectors, and Total-Body Systems — Georges El Fakhri (Yale)
- 12:30 - 12:50 pm: Inflammation in the White Matter: Chronic Active Lesions and the Normal-Appearing Brain — Susan Gauthier (Weill Cornell Medicine)
- 12:50 - 1:10 pm: Inflammation in the Gray Matter and at the Brain's Borders: Cortex, Meninges, and Choroid Plexus — Caterina Mainero (Massachusetts General Hospital)
- 1:10 - 1:30 pm: Beyond Inflammation: Tissue Injury, Repair, and Neurodegeneration — Bruno Stankoff (Paris Brain Institute)
- 1:55 - 2:15 pm: TSPO PET as a Phase II Endpoint: Feasibility, Population, and Target Tissue — Matthew Brier (Washington University in St. Louis)
- 2:15 - 2:35 pm: Myelin PET in Remyelination Trials: Advantages Over and Alongside MRI — Benedetta Bodini (Paris Brain Institute)
- 2:35 - 2:55 pm: Lessons From Alzheimer's Disease: How PET Became a Multisite Endpoint — Susan Landau (UC Berkley)